THAT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - N4 Pharma PLC

Watchlist Manager

Watchlist

Price: 0.65 GBX Market Closed

Market Cap: £5.4m

	N4 Pharma PLC LSE:THAT	UK
	Sogeclair SA PAR:ALSOG	FR
J	JKX Oil and Gas PLC F:JKX	UK
C	Carmax Inc XBER:XA4	US
S	SNP Schneider Neureither & Partner SE XBER:SHF	DE
	Agree Realty Corp F:AGL	US
R	Reckitt Benckiser Group PLC XBER:3RB	UK
	Stora Enso Oyj OTC:SEOJF	FI
S	Silvercorp Metals Inc XMUN:S9Y	CA
H	HALEON PLC XBER:H6D0	UK
M	Marks and Spencer Group PLC XMUN:MA6	UK
P	PTG Energy PCL SET:PTG	TH
	Bellerophon Therapeutics Inc OTC:BLPH	US

Profitability Summary

N4 Pharma PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-16 920%

Negative 3Y Average Operating Margin

-31 599%

Negative Net Margin

-15 007%

Negative 3Y Average Net Margin

-27 812%

Negative Free Cash Flow Margin

-14 437%

Negative 3Y Average Free Cash Flow Margin

-26 105%

Negative ROE

-71%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1 187%

ROIC is Increasing

-2 885% > -1 085%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.